1. Isoprostanes and related compounds: update 2006. Milne GL, Morrow JD (2006) Antioxid Redox Signal 8(7-8): 1379-84
    › Primary publication · 16910785 (PubMed)
  2. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Landar A, Zmijewski JW, Dickinson DA, Le Goffe C, Johnson MS, Milne GL, Zanoni G, Vidari G, Morrow JD, Darley-Usmar VM (2006) Am J Physiol Heart Circ Physiol 290(5): H1777-87
    › Primary publication · 16387790 (PubMed)
  3. Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2. Kozak KR, Milne GL, Morrow JD, Cuiffo BP (2006) Nat Clin Pract Rheumatol 2(8): 452-6; quiz following 456
    › Primary publication · 16932737 (PubMed)
  4. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. Gao L, Yin H, Milne GL, Porter NA, Morrow JD (2006) J Biol Chem 281(20): 14092-9
    › Primary publication · 16569632 (PubMed)
  5. Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. Milne GL, Morrow JD, Picklo MJ (2006) Neurosci Lett 405(3): 172-4
    › Primary publication · 16875780 (PubMed)
  6. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. Musiek ES, Breeding RS, Milne GL, Zanoni G, Morrow JD, McLaughlin B (2006) J Neurochem 97(5): 1301-13
    › Primary publication · 16638022 (PubMed) · PMC2881557 (PubMed Central)
  7. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA (2006) Clin Cancer Res 12(11 Pt 1): 3381-8
    › Primary publication · 16740761 (PubMed)
  8. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation. Milne GL, Musiek ES, Morrow JD (2005) Antioxid Redox Signal 7(1-2): 210-20
    › Primary publication · 15650409 (PubMed)
  9. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Musiek ES, Yin H, Milne GL, Morrow JD (2005) Lipids 40(10): 987-94
    › Primary publication · 16382569 (PubMed)
  10. Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A(2t)-isoprostane in vivo. Milne GL, Gao L, Porta A, Zanoni G, Vidari G, Morrow JD (2005) J Biol Chem 280(26): 25178-84
    › Primary publication · 15878849 (PubMed)